Scarica l'app Stockscreener
5.31
1.85%
-0.10
Pre-mercato:
5.39
0.08
+1.51%
Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie
(ORIC) Technical Data - news.stocktradersdaily.com
Dimensional Fund Advisors LP Acquires 103,237 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Q2 EPS Estimates for ORIC Pharmaceuticals Raised by Wedbush - MarketBeat
Oppenheimer Issues Pessimistic Forecast for ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price - MarketBeat
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - ADVFN
Cantor Fitzgerald Reaffirms "Overweight" Rating for ORIC Pharmaceuticals (NASDAQ:ORIC) - MarketBeat
Balyasny Asset Management L.P. Purchases 424,194 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
ORIC Pharmaceuticals (NASDAQ:ORIC) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
ORIC Pharmaceuticals' (ORIC) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
ORIC Pharmaceuticals (ORIC) Receives Increased Price Target from H.C. Wainwright | ORIC Stock News - GuruFocus
ORIC Pharmaceuticals (ORIC) Price Target Raised by Analyst | ORIC Stock News - GuruFocus
Wedbush Boosts Earnings Estimates for ORIC Pharmaceuticals - Defense World
Price T Rowe Associates Inc. MD Has $10.45 Million Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Schonfeld Strategic Advisors LLC Takes $5.85 Million Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
1,732,571 Shares in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Bought by Boxer Capital Management LLC - MarketBeat
Ratio Review: Analyzing ORIC Pharmaceuticals Inc (ORIC)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
MetLife Investment Management LLC Has $336,000 Stake in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Purchased by Wells Fargo & Company MN - Defense World
ORIC Pharmaceuticals Reports Q1 2025 Progress and Plans - TipRanks
ORIC Pharmaceuticals (ORIC) Target Price Lowered by Oppenheimer | ORIC Stock News - GuruFocus
ORIC Pharmaceuticals (ORIC) Receives Reiterated "Overweight" Rat - GuruFocus
Oppenheimer Adjusts Price Target on ORIC Pharmaceuticals to $12 From $15, Maintains Outperform Rating - marketscreener.com
Oppenheimer Revises Price Target for ORIC Following Quarterly Re - GuruFocus
Oppenheimer Revises Price Target for ORIC Following Quarterly Results | ORIC Stock News - GuruFocus
Barclays PLC Grows Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
ORIC Pharmaceuticals’ (ORIC) Buy Rating Reaffirmed at HC Wainwright - Defense World
ORIC Pharmaceuticals Inc Reports Q1 2025 Earnings: EPS Misses Estimate at -0.51, Revenue Remains at $0 Million - GuruFocus
Oric Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Oric Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates - GlobeNewswire
ORIC Pharma Secures Major J&J Partnership, Reports 5 Clinical Readouts Coming in Cancer Drug Pipeline - Stock Titan
Invesco Ltd. Grows Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
ORIC Pharmaceuticals (ORIC) Rating Reiterated at HC Wainwright & Co. | ORIC Stock News - GuruFocus
ORIC Pharmaceuticals (ORIC) to Release Quarterly Earnings on Monday - Defense World
(ORIC) Long Term Investment Analysis - news.stocktradersdaily.com
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News - GuruFocus
Oncology Biotech ORIC Issues Major Equity Package: 32,400 Options Plus RSUs for New Talent - Stock Titan
An analyst sees good growth prospects for ORIC Pharmaceuticals Inc (ORIC) - Sete News
Market Watch: ORIC Pharmaceuticals Inc (ORIC)’s Noteworthy Drop, Closing at 5.57 - DWinneX
Is ORIC Pharmaceuticals Inc (ORIC) worth investing in despite its overvalued state? - uspostnews.com
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Sold by Legal & General Group Plc - Defense World
Legal & General Group Plc Has $266,000 Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - The AM Reporter
ORIC Pharmaceuticals Inc’s Shares Reel: -51.58% Quarterly Revenue Decline Amid 401.98M Market Cap - investchronicle.com
ORIC Pharmaceuticals Inc (ORIC) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):